Search
MLN576
go.drugbank.com/drugs/DB06517ExperimentalXR11576 (MLN576) is a novel monophenazine with a mechanism of action that includes interaction with both topoisomerase (Topo) I and II.[A234609]
KOS-1584
go.drugbank.com/drugs/DB05903InvestigationalKOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation. … KOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors.
SLV319
go.drugbank.com/drugs/DB05077ExperimentalIt is developed for the treatment of obesity and other metabolic disorders.
FAV-201
go.drugbank.com/drugs/DB06130ExperimentalFAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
CRA-028129
go.drugbank.com/drugs/DB05951ExperimentalCRA-028129 is cathepsin S inhibitor which is under investigation for the treatment of psoriasis.
VX-702
go.drugbank.com/drugs/DB05470InvestigationalVX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor.
PEV3A
go.drugbank.com/drugs/DB05144InvestigationalPEV3A is a prophylactic malaria vaccine that acts against various stages of the disease. It is a two-component vaccine that contains the virosome formulated peptide mimetics PEV301 and PEV302.
Prinomastat
go.drugbank.com/drugs/DB05100InvestigationalAs a lipophilic agent, prinomastat crosses the blood-brain barrier. … Prinomastat is a synthetic hydroxamic acid derivative with potential antineoplastic activity.
Modafinil
go.drugbank.com/drugs/DB00745ApprovedInvestigationalModafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. … The prexin neuron activation is associated with psychoactivation and euphoria.
SYN-101
go.drugbank.com/drugs/DB05958ExperimentalSYN-101 is an investigational antibody-drug conjugate developed for the treatment of cancer. … SYN101 is comprised of an immune cell specific antibody linked to an ALK5 inhibitor payload to selectively block TGF-b signalling in immune cells.